Pharmaceutical research in the context of cancer has made significant strides over the past few decades. Advances in molecular biology, genomics, and immunology have led to a deeper understanding of cancer mechanisms and the development of new treatment paradigms. The focus has shifted from traditional chemotherapy to more targeted therapies and immunotherapies that offer the potential for higher efficacy and fewer side effects.
